Brown & Brown Reports Strong Q1 Revenue & Net Income Growth, Flat Organic Revenue, and Diluted EPS Decline
Summary
Brown & Brown reported robust Q1 2026 revenue and net income growth, primarily driven by acquisitions, but experienced flat organic revenue growth and a decline in diluted EPS. The company also completed a significant share repurchase program.
Key Events
-
Strong Revenue and Net Income Growth
Total revenues increased 35.4% to $1.901 billion, and net income attributable to the company rose 28.7% to $426 million in Q1 2026 compared to Q1 2025.
-
Flat Organic Revenue Growth
Organic revenue growth was 0.0% for Q1 2026, a significant slowdown from 6.5% in Q1 2025, indicating growth is primarily acquisition-driven.
-
Diluted EPS Decline
Diluted EPS decreased by 7.8% to $1.06 in Q1 2026 from $1.15 in Q1 2025, despite higher net income, partly due to the impact of contingently issuable shares and a non-cash mark-to-market gain on escrow liability.
-
Significant Share Repurchase
The company completed a $250 million Accelerated Share Repurchase (ASR) program, acquiring 3,574,890 shares, with $1.15 billion remaining under authorization.
Analysis
Brown & Brown's first-quarter results demonstrate strong top-line and net income growth, largely fueled by recent acquisitions, including the Accession deal in Q3 2025. However, the flat organic revenue growth is a key concern, suggesting that the company's core business is not expanding without external additions. The decline in diluted EPS, despite increased net income, is a negative for shareholders, influenced by factors like contingently issuable shares and non-cash accounting adjustments. The substantial share repurchase program indicates management's commitment to returning capital and potentially offsetting dilution, but the increased debt and associated interest expense highlight the financial costs of its aggressive M&A strategy. Investors should monitor organic growth trends and the impact of future acquisitions on profitability and leverage.
At the time of this filing, BRO was trading at $66.35 on NYSE in the Finance sector, with a market capitalization of approximately $22.5B. The 52-week trading range was $63.29 to $116.41. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.